Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus

NCT02467179 · University of California, San Diego · Updated 27 June 2019

What is being tested
Amigo™ Robotic Catheter Manipulation; Manual Catheter Manipulation
For
Atrial Fibrillation; Atrial Flutter
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 50 people. The full rules are on the registry page.
Where
United States
When
Starts or started March 2015, ends 30 March 2018. Registered 9 June 2015.
Results
Posted on the registry on 27 June 2019.

In the researchers' words

The purpose of this study is to compare standard manual and robotically controlled catheter ablation of the cavo-tricuspid isthmus (CTI) as a treatment for atrial flutter. Ablation of the CTI is standard treatment for patients with a history of atrial flutter, and those undergoing ablation for atrial fibrillation. Both manual and robotic catheter manipulation are used in standard clinical practice at The University of California, San Diego (UCSD) for ablation.
ClinicalTrials.gov, NCT02467179

Sites

  • Sulpizio Cardiovascular CenterLa Jolla, California, United States